Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,504 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07821957Recruiting
Flow diverter stent for wide-neck brain aneurysms
This study tests a new stent, a small mesh tube placed inside the artery to block blood flow to a wide-neck brain aneurysm, reducing its rupture risk. It aims to see how safe and effective this stent is for people aged 22–80.
Beijing, Beijing MunicipalityAges 22–80 - NCT07818239Enrolling by invitation
How diet affects eye blood vessels
This study looks at how different foods and drinks affect the blood vessels in your eyes. By taking pictures of your retina (the back of the eye) after certain meals, researchers hope to learn more about diet and eye health.
ViennaAges 18 years+ - NCT07817329Recruiting
Nutritional support for advanced lung cancer patients
This trial tests whether providing extra nutritional support to people with advanced lung cancer before they start their first chemotherapy or other treatment can improve their health. The goal is to see if good nutrition helps patients tolerate treatment better and maintain their strength.
Peschiera del Garda, VeronaAges 18 years+ - NCT07824518Recruiting
Comparing two bone graft materials after wisdom tooth removal
This study compares two types of bone graft material used to help healing after removing impacted lower wisdom teeth. It tests whether a graft made from your own tooth works as well as one from a cow (bovine xenograft).
Madrid, MadridAges 18 years+ - NCT07818564RecruitingPhase 1
Psilocybin study on belief and insight in healthy adults
This study tests whether a single dose of psilocybin (a psychedelic compound) can help people update their beliefs and gain new insights. It's for healthy adults with some prior psychedelic experience, and it's a small pilot study at Brown University.
Providence, Rhode IslandAges 18 years+ - NCT07818889Recruiting
Newer therapies for people thinking about suicide
This study looks at newer therapies for people who are having thoughts of suicide or have recently tried to harm themselves. The goal is to see how well these treatments work and how they can be improved to help people feel safer and recover.
Columbus, OhioAges 18 years+ - NCT07817589Recruiting
Adding yoga to exercise rehab for heart failure
This study tests whether adding yoga to a hospital-based cardiac rehabilitation program can improve the health and well-being of people with heart failure. It might help you feel better and manage your condition more effectively.
Dharwad, KarnatakaAges 18 years+ - NCT07825831Recruiting
Personalized heat-risk alerts for chronic conditions
This study uses AI to send personalized heat warnings to people with chronic health conditions like high blood pressure, diabetes, or obesity. The goal is to help you avoid heat-related health problems during the six-week program.
Gujranwala, Punjab ProvinceAges 18 years+ - NCT07823842Recruiting
Biologics for asthma and COPD
This study looks at how well medicines called biologics work for people with asthma or COPD. Biologics are special shots that target certain parts of the immune system to reduce inflammation. Researchers want to see if these treatments can help control symptoms and prevent flare-ups.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07824089Recruiting
Exercise training to reduce alcohol use and liver damage
This study tests whether a supervised exercise program can help people with alcohol-related liver disease drink less and reduce liver injury. It may work by boosting a natural hormone called FGF21, which helps regulate alcohol intake.
Cleveland, OhioAges 18 years+ - NCT05570929Recruiting
Study of kidney changes before and around donation
This study follows people who are planning kidney donation or a kidney transplant to better understand how kidney function changes over time. It may help researchers predict risk and improve care by studying health markers in detail.
BerlinAges 18–75 - NCT06482788RecruitingPhase 2
Immunotherapy plus chemo before & after junction cancer surgery
This trial tests giving an immunotherapy drug (adebrelimab) along with two chemotherapy drugs (capecitabine and oxaliplatin) before and after surgery for a specific type of stomach-cancer junction tumor. It aims to see if this combination is safe and effective in shrinking the tumor and improving outcomes.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT03674788Recruiting
Heart valve patients getting a catheter procedure
This is a registry that follows people who are having a catheter-based treatment for a heart valve problem. It helps doctors understand how these procedures work in real life and may improve future care.
LeuvenAges Any age - NCT05592717Recruiting
YUTIQ implant for chronic non-infectious eye inflammation
This trial tests whether a small steroid implant placed inside the eye (YUTIQ 0.18 mg) can control chronic non-infectious uveitis. It may help reduce active inflammation and prevent flare-ups, as long as you’ve had recent signs of active disease and can follow the medication and eye-visit rules.
Tianjin, Tianjin MunicipalityAges 18–70 - NCT05352178RecruitingPhase 3
Targeted treatment for few-spread prostate cancer spots
This Phase 3 trial tests whether treating only a small number of prostate cancer metastases can help people with “oligorecurrent” (limited repeat) prostate cancer. It may reduce cancer activity while avoiding broader whole-body treatment for some patients.
LeuvenAges 18 years+ - NCT05870475RecruitingPhase 2
Interferon plus ruxolitinib for hydroxyurea-resistant polycythemia vera
This Phase 2 trial tests a combination of pegylated interferon and ruxolitinib in adults with polycythemia vera who can’t tolerate hydroxyurea or don’t respond well to it. If you qualify, it may help control blood counts and disease symptoms when standard treatment hasn’t worked.
TianjinAges 18 years+ - NCT06483347RecruitingPhase 2
Immunotherapy combo for inoperable lung cancer
This trial tests a combination of immunotherapy drugs (checkpoint inhibitors) delivered directly into the liver along with standard treatment, as a first option for people with inoperable lung cancer. It aims to see if this approach can help shrink tumors and improve outcomes.
Guangzhou, GuangdongAges 18–75 - NCT05635487RecruitingPhase 2
Neoadjuvant treatment for HER2-positive breast cancer with SHR-A1811
This trial tests whether SHR-A1811 alone, or together with pyrotinib, given before surgery, can shrink HER2-positive breast cancer. It may help you respond better to treatment while making surgery easier.
Shenyang, LiaoningAges 18–75 - NCT06489080Recruiting
Heart attack follow-up study on survival and health
This study looks at how people with heart attacks do over time, including their survival and any heart-related events. It helps doctors understand more about the condition and how to improve care.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06306456RecruitingPhase 1/Phase 2
GH21 combined with osimertinib for advanced lung cancer
This trial tests a new drug (GH21) combined with the targeted therapy osimertinib (Tagrisso) for people with advanced non-small cell lung cancer that has an EGFR mutation and has stopped responding to a similar treatment. The goal is to see if the combination can help when the cancer has progressed.
Hefei, AnhuiAges 18 years+ - NCT07809256RecruitingPhase 3
Combination treatment for advanced lung cancer with a RET gene change
This trial tests a combination of two medicines (pembrolizumab and lenvatinib) for people with advanced non-small cell lung cancer that has a specific RET gene change. The treatment may help slow down or shrink the cancer, and the study checks how well people tolerate it.
Saint PetersburgAges 18 years+ - NCT07810530RecruitingPhase 2
Mouthwash with laser for preventing mouth sores in stem cell transplant
This study tests whether a special mouthwash made from copaiba (a natural oil) plus low-level laser therapy can prevent mouth sores caused by high-dose chemotherapy before a stem cell transplant. It might help reduce pain and trouble eating during your transplant treatment.
Rio de Janeiro, Rio de JaneiroAges 12 years+ - NCT07811570Recruiting
Finding early signs of kidney damage after heart surgery
This study looks for early signs in your blood or urine that can predict if you might develop kidney damage after heart or blood vessel surgery. It aims to help doctors identify high-risk patients earlier so they can protect their kidneys.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07811726RecruitingPhase 2
Eye drops for wet age-related macular degeneration
This trial tests a new eye drop called NT-101 for people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The goal is to see if the drops can improve vision and reduce fluid in the eye, possibly as a less invasive alternative to injections.
Bonita Springs, FloridaAges 50 years+
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,504 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.